CompletedPhase 1

Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults

Germany113 participantsStarted 2001-02

Plain-language summary

This study was designed to investigate the safety and immunogenicity of Chiron's investigational H. pylori (HP3) vaccine

Who can participate

Age range18 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy * Ages 18-40 * Negative for H. pylori infection * Contraception for females Exclusion Criteria: * Present or past H. pylori infection * Medically significant gastroduodenal disease * Recent corticosteroid use * Bleed diathesis * Use of antibiotics used to treat H. pylori infection

What they're measuring

Safety measures: injection site and systemic reactions

Timeframe: 5 months

Trial details

NCT IDNCT00613665

SponsorNovartis Vaccines

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2001-12

View on ClinicalTrials.gov More Helicobacter Pylori trials